EquityBulls

Latest News

Keywords Selected: Capsules

Stock Report

Shelter Pharma Limited Launches D3 Cure Capsules
ZIM Laboratories Ltd receives approval from CDSCO - Directorate General of Health Services for Naproxen + Esomeprazole Capsules
Zydus receives final approval from USFDA for Diroximel Fumarate Delayed-Release Capsules, 231 mg
Alembic Pharmaceuticals Ltd announces USFDA Final Approval Dexlansoprazole Delayed Release Capsules, 30 mg and 60 mg
Zydus receives approval from China's NMPA for Venlafaxine Extended-Release Capsules, 75 mg and 150 mg
Zydus receives tentative approval from USFDA for Budesonide delayedrelease capsules, 4 mg
Lupin receives approval from U.S. FDA for Lenalidomide Capsules
Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules for the U.S. market
Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg and 400 mg
Aayush Wellness Ltd launches Brain Fuel Capsules
Zydus receives final approval from USFDA for Isotretinoin Capsules USP, 10 mg 20 mg, 25 mg, 30 mg, 35 mg and 40 mg
Strides strengthens Anti-Inflammatory Portfolio with USFDA Approval for Celecoxib Capsules, 100 mg, 200 mg, and 400 mg
ZIM Laboratories Ltd receives Marketing Authorization for Dimethyl Fumarate (120 mg & 240 mg) Modified Release Capsules in Portugal, Europe
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Divalproex Sodium Delayed-Release Capsules USP, 125 mg
Alembic Pharmaceuticals announces USFDA Final Approval for Diltiazem Hydrochloride Extended-Release Capsules USP, 120 mg, 180 mg, and 240 mg
Zydus receives final approval from USFDA for Enzalutamide Capsules, 40 mg
Zydus receives final approval from USFDA for Amantadine extended-release capsules 68.5 mg and tentative approval for 137 mg
Relonchem Limited receives Marketing Authorization from UKMHRA for its products
Glenmark Pharmaceuticals receives ANDA approval for Topiramate Capsules USP, 15 mg and 25 mg
Zydus receives tentative approval from USFDA for Diroximel Fumarate Delayed-Release Capsules, 231 mg
Alembic Pharmaceuticals announces USFDA Final Approval for Doxycycline Capsules, 40 mg
Alembic Pharmaceuticals announces USFDA Final Approval for Dabigatran Etexilate Capsules, 75 mg and 150 mg and Tentative approval for Dabigatran Etexilate Capsules, 110 mg
Glenmark receives ANDA approval for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg - OTC
Caplin Point gets Colombia approval for Softgel Capsules